Study Melanoma with Peptide Innovations & New Literature

Study Melanoma with Peptide Innovations & New Literature

Published on 11/08/2022

common melanoma- associated antigens, e.g. MAGE, PRAME or NY-ESO, with new products continuously added to the catalog

for T-cell immunity profiling & epitope discovery

immunodominant epitopes representing melanoma-associated antigens

for stimulation of antigen-specific T cells in T cell assays

custom peptides produced under stringent quality regulations

for development of novel vaccines & cell therapies and clinical immune monitoring

high density or multiwell peptides microarrays

for epitope resolved humoral immune response profiling and antibody epitope mapping

Lanscape of Helper and Regulatory Antitumour CD4+ T cells in Melanoma Oliveira et al., Nature (2022) – PMID: 35508657

Local Delivery of low-dose anti–CTLA-4 to the Melanoma Lymphatic Basin leads to systemic T reg Reduction and Effector T cell Activation Van Pul et al., Science Immunology (2022) – PMID: 35857579

Functional T Cell Reactivity to Melanocyte Antigens is lost during the Progression of Malignant Melanoma, but Is restored by Immunization Przybyla et al., Cancers (Basel) (2021) – PMID: 33435427

Identification of Novel HLA-Restricted Preferentially Expressed Antigen in Melanoma Peptides to Facilitate Off-The-Shelf Tumor-Associated Antigen-Specific T-Cell Therapies Stanojevic et al., Cytotherapy (2021) – PMID: 33832817

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model Akache et al., Pharmaceutics (2021) – PMID: 33673382

Neoantigens in Cancer Immunotherapy – Review Schumacher & Schreiber, Science (2015) – PMID: 25838375

An immunogenic personal Neoantigen Vaccine for Patients with Melanoma – LetterOtt et al., Nature (2017) – PMID: 28678778

Find more references.

If you have any questions or want to discuss our large varity of custom peptide synthesis formats, pease contact us.